$23m aid announced for Ebola vaccine manufacture
The US HHS has committed to a contribution to help Merck manufacture its investigational V920 vaccine for the treatment of Ebola.
List view / Grid view
The US HHS has committed to a contribution to help Merck manufacture its investigational V920 vaccine for the treatment of Ebola.
New research has found that of the 38 warning letters handed out by the FDA in 2019, the US and India received the vast majority.
A warning letter has been sent to Emcure Pharmaceuticals after an FDA facility inspection found that the company did not adequately investigate sterility failures.
This series investigates cannabinoids and pharmaceutical interest with industry experts explaining the position of the ingredient. In this second piece, we discuss the challenges, legal implications and perceptions of cannabinoids.
The worldwide trade of the cephalosporin class of antibiotics will increase to $14.1 billion by the end of 2025.
A leaked government dossier has stated that in the event of a no-deal Brexit, the UK will face severe medicinal shortages.
An MHRA consultation is due to end on 31 August, with public comments on AQbD principles closing soon.
Lidocaine topical cream and liquid gel products are being recalled as the lidocaine amount is higher than the label states.
The Philippines is considering re-introducing a dengue vaccine whose use was ceased because of links to several deaths.
The BioCapt® Single-Use Microbial Impactor is a lightweight, integrated air sampler designed to be used with both portable and remote monitoring systems in remote sampling settings.
Rising temperatures will likely accelerate the spread of vector-borne diseases, resulting in an increased demand for vaccines. European Pharmaceutical Review investigates a Morgan Stanley report on the pharmaceutical beneficiaries of climate change.
Over the past couple of years, the European Medicines Agency and US Food and Drug Administration have given approvals to a handful of pharmaceutical companies to manufacture drug products using continuous manufacturing processes.
The FDA has handed a CRL to Biohaven for its ALS treatment awaiting approval due to concerns regarding the medication’s API.
Substandard and counterfeit drugs can negatively impact the pharmaceutical industry and patients. Here, we investigate counterfeits in south-east Asia and possible solutions.
In this webinar, we will introduce you to the microbial environmental monitoring in production isolators. You will learn how to be compliant and ease your workflow.